During the past decade, Heidelberg Repatriation Hospital; Medical and Cognitive Research Centre conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 15 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 11 clinical trials were completed. i.e. 137.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Heidelberg Repatriation Hospital; Medical and Cognitive Research Centre" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Pfizer" with 6 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials sponsored, "Anavex Life Sciences Corp." with 2 trials sponsored and "Biogen" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Heidelberg Repatriation Hospital; Medical and Cognitive Research Centre" #1 collaborator was "Arbeitsgruppe Lebermetastasen und Tumoren" with 1 trials as a collaborator, "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 1 trials as a collaborator, "Bausch Health Americas, Inc." with 1 trials as a collaborator and "British Medical Research Council" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Heidelberg Repatriation Hospital; Medical and Cognitive Research Centre" are "Alzheimer's Disease" (12 trials), "Alzheimer Disease" (5 trials), "Epilepsy" (3 trials), "Obesity" (3 trials) and "Alzheimers Disease" (2 trials). Many other conditions were trialed in "Heidelberg Repatriation Hospital; Medical and Cognitive Research Centre" in a lesser frequency.

Most popular intervention types in "Heidelberg Repatriation Hospital; Medical and Cognitive Research Centre" are "Drug" (40 trials), "Biological" (3 trials), "Radiation" (3 trials), "Procedure" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Gantenerumab" (6 trials), "Crenezumab" (2 trials), "Tirzepatide" (2 trials) and "adjuvant therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Heidelberg Repatriation Hospital; Medical and Cognitive Research Centre" are 43 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Heidelberg Repatriation Hospital; Medical and Cognitive Research Centre". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Heidelberg Repatriation Hospital; Medical and Cognitive Research Centre, 1 suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Heidelberg Repatriation Hospital; Medical and Cognitive Research Centre, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".